BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2000
View Archived Issues
NIAID awards grants for drug and vaccine development
Read More
Epicyte receives grants for sexual health applications
Read More
Advanced Biotherapy's anti-interferon gamma drug shows promise in the clinic
Read More
Clinical trial results for IL-2/SEB combination therapy for melanoma positive
Read More
PI-88's novel mechanism of action revealed; compound enters two new trials
Read More
NIDA grant awarded to Nabi for nicotine vaccine research
Read More
Myriad reports location of prostate cancer susceptibility gene
Read More
AxyS selects lead compound in asthma program
Read More
Ertapenem displays activity against a wide range of anaerobes causing intraabdominal infection
Read More
Salus receives SBIR grant for cystic fibrosis research
Read More
FDA approves first and only once-monthly contraceptive for women
Read More
Periostat now available in the U.K., its first European market
Read More
Coulter's Bexxar assigned priority review status by FDA
Read More
Parke-Davis reports SAR investigations on novel non-nucleoside antiviral agents
Read More
Initial evaluation of female sexual response using MS-325
Read More
Positive effects of PARP inhibitor in animal model of acute inflammation
Read More
Preclinical data support clinical trials of repifermin in ulcerative colitis
Read More
Marine natural product shows promise for hyperproliferative and inflammatory conditions
Read More
CRL-8256, with potential in cancer chemotherapy, emerges from joint French and Belgian research
Read More
Favorable ML-3000 clinical data presented during OARSI congress
Read More
Numerous lead compounds emerge from Versicor's oxazolidinone combinatorial libraries
Read More
Sulfonamides designed by two major labs as potential Alzheimer's disease therapies
Read More
NOS inhibitors in the Pfizer pipeline reported in patent literature
Read More
Novel target for anticancer therapy and new compounds discovered at Klinge
Read More
Roche's new NK1 receptor antagonists intended particularly for depression and emesis
Read More
New PDE4 inhibitors and methods of treating asthma
Read More
Boehringer Ingelheim identifies new series of cytokine-inhibitory antiinflammatory agents
Read More
International patent coverage obtained for new thrombin inhibitors from Boehringer Ingelheim
Read More